ペンニードルの世界市場：種類、長さ、治療、購入、地域別分析...市場調査レポートについてご紹介

1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 20)
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Insights From Primary Sources
2.2.2.3 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Research Design
2.5 Market Data Validation and Triangulation
2.6 Assumptions for the Study

3 Executive Summary (Page No. – 30)
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights (Page No. – 36)
4.1 Market Overview
4.2 Geographic Analysis: Market, By Length
4.3 Market, By Type
4.4 Market, By Length
4.5 Market, By Mode of Purchase
4.6 Geographic Snapshot: Market

5 Market Overview (Page No. – 40)
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Favorable Reimbursement Environment and Government Support in Selected Countries
5.3.1.2 Advantages of Insulin Pens Over Syringes and Vials
5.3.1.3 Technological Advancements
5.3.1.4 Growing Diabetic Population
5.3.1.5 Conferences, Meetings, and Congresses to Create Pen Needle Awareness
5.3.2 Restraints
5.3.2.1 Poor Reimbursement Structure in Developing Countries
5.3.2.2 Needle Anxiety
5.3.2.3 Alternative Drug Delivery Methods
5.3.2.3.1 Oral Diabetic Agents and Oral Insulin
5.3.2.3.2 Inhalable Insulin
5.3.2.3.3 Nanotechnology to Aid in Transdermal and Inhalational Route of Administering Proteins and Peptides
5.3.2.4 Severe Shortage of Endocrinologists in the U.S.
5.3.2.5 Reuse of Pen Needles
5.3.3 Opportunities
5.3.3.1 Safety Needles
5.3.3.2 GLP-1 Analogues
5.3.4 Challenges
5.3.4.1 Minimizing the Reuse of Standard Pen Needles
5.3.4.2 Resistance Against Switching From Conventional Devices to Advanced Devices

6 Industry Insights (Page No. – 52)
6.1 Introduction
6.2 Porter’s Five Forces Analysis
6.2.1 Threat of New Entrants
6.2.2 Bargaining Power of Suppliers
6.2.3 Bargaining Power of Buyers
6.2.4 Segment Rivalry
6.2.5 Threat of Substitutes
6.3 Competitive Intensity
6.3.1 Evaluation Parameters
6.3.2 Scoring Methodology
6.3.3 Competitive Intensity Score, By Company
6.3.3.1 Competitive Intensity Score for BD
6.3.3.2 Competitive Intensity Score for Novo Nordisk
6.3.3.3 Competitive Intensity Score for Ypsomed
6.3.4 Competitive Intensity Mapping of BD, Novo Nordisk, and Ypsomed
6.3.5 Comparison of Evaluation Parameters, By Company
6.3.5.1 Pricing
6.3.5.2 Product Portfolio
6.3.5.3 Product Launches/Technological Advancements
6.3.5.4 Production Capacity (2015)
6.3.5.5 Geographical Presence
6.3.5.6 Promotional/Marketing Activities
6.3.5.7 Sponsorships/Donations/Education/Awareness Campaigns
6.3.5.8 M&As, Partnerships, Collaborations, Agreements, and Expansions
6.3.5.9 Years of Experience
6.3.5.10 Certifications/Accreditations/Awards

7 Pen Needles Market, By Type (Page No. – 72)
7.1 Introduction
7.2 Standard Pen Needles
7.3 Safety Pen Needles

8 Pen Needles Market, By Needle Length (Page No. – 79)
8.1 Introduction
8.2 4mm
8.3 5mm
8.4 6mm
8.5 8mm
8.6 10mm
8.7 12mm

9 Pen Needles Market, By Therapy (Page No. – 85)
9.1 Introduction
9.2 Insulin
9.3 GLP-1
9.4 Growth Hormones

10 Pen Needles Market, By Mode of Purchase (Page No. – 91)
10.1 Introduction
10.2 Retail
10.3 Non-Retail

11 Pen Needles Market, By Region (Page No. – 95)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.1.1 Growing Diabetes Prevalence and Favorable Reimbursement Scenario for Pen Needles
11.2.1.2 Federal Initiatives to Stimulate the U.S. Pen Needles Market
11.2.1.3 Focus of Leading Players on Increasing Market Penetration in the U.S.
11.2.1.4 Improvements in Pen Needle Technologies to Eliminate Needlestick Injuries
11.2.1.5 Low Penetration of Pen Injectors in the U.S. as Compared to Europe
11.2.2 Canada
11.2.2.1 High Diabetes Prevalence
11.2.2.2 Regulations for the Use of Safety-Engineered Needles
11.2.2.3 Government Support for Pen Needles in Alberta
11.3 Europe
11.3.1 Germany
11.3.1.1 Regulatory Framework to Minimize Needlestick Injuries & Boost Use of Safety-Engineered Devices
11.3.1.2 High Diabetes Prevalence and Reimbursement for Pen Needles
11.3.2 U.K.
11.3.2.1 Activities to Pool Funds for Diabetes Care & Research
11.3.3 France
11.3.3.1 Conferences and Exhibitions to Increase Exposure for Pen Needles Players in French Market
11.3.3.2 Higher Insurance Coverage and Increase in Aging Population and Affordability
11.3.4 Italy
11.3.4.1 Wide Regional Variations in Terms of Benefits and Coverage to Slow Growth in Italy
11.3.4.2 Awareness Campaigns for Diabetes in Italy to Propel the Market Growth
11.3.5 Spain
11.3.5.1 Large Pool of Diabetic Population, Regulations Mandating the Use of Safety Pen Needles
11.3.6 Rest of Europe
11.3.6.1 High Diabetes Prevalence in Russia, Poland, Romania, and Ukraine
11.4 Asia
11.4.1 Japan
11.4.1.1 High Adoption of Insulin Pens and Approval of Injectable Insulin
11.4.2 China
11.4.2.1 Growing Presence of Global and Local Players in China
11.4.2.2 High Diabetes Incidence and Adoption of Insulin Pens
11.4.2.3 High Reuse Rate & Lack of Reimbursement to Limit Market Growth
11.4.3 India
11.4.3.1 Growing Presence of Global Players in India
11.4.3.2 Low Pen Needle Penetration, Lack of Awareness to Restrain Market Growth
11.4.4 Rest of Asia
11.4.4.1 Vietnam, A Potential Market for Pen Needles
11.4.4.2 Increase in Pen Needles Likely in Singapore & Malaysia
11.5 Rest of the World (RoW)
11.5.1 Latin America
11.5.1.1 Increasing Diabetic Population and Rising Awareness on Diabetes in Brazil
11.5.2 Pacific Countries
11.5.2.1 Amendments in Ndss to Increase Access to Diabetic Products in Australia
11.5.2.2 Favorable Reimbursement Scenario and Presence of Charity Organizations in New Zealand
11.5.3 Middle East & Africa
11.5.3.1 Presence of Local & International Pen Needle Manufacturers and Rising Awareness on Pen Needles to Bolster the Market
11.5.3.2 Increasing Diabetic Population, Rising Awareness on Diabetes

12 Pen Needle Distributor List (Page No. – 141)

13 Competitive Landscape (Page No. – 149)
13.1 Overview
13.2 Market Share Analysis
13.2.1 Introduction
13.2.2 Becton, Dickinson & Co.
13.2.3 Novo Nordisk A/S
13.2.4 Ypsomed Holding AG
13.2.5 Others
13.3 Competitive Situation and Trends
13.3.1 Marketing and Promotion
13.3.2 Expansion
13.3.3 Product Launch
13.3.4 Others

14 Company Profiles (Page No. – 158)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
14.1 Introduction
14.2 Becton, Dickinson and Company
14.3 Novo Nordisk A/S
14.4 Ypsomed Holding AG
14.5 Owen Mumford, Ltd.
14.6 HTL-Strefa S.A.
14.7 B. Braun Melsungen
14.8 Terumo Corporation
14.9 Ultimed, Inc. (LDI, Ltd.)
14.10 Allison Medical, Inc.
14.11 Artsana S.P.A.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

15 Appendix (Page No. – 175)
15.1 Discussion Guide
15.2 Company Developments (2013-2016)
15.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
15.4 Introducing RT: Real-Time Market Intelligence
15.5 Available Customizations
15.6 Related Reports